🇺🇸
United States · US · US:0024-5869_49201ad7-68f7-407c-959f-852591703f96
TOUJEO
In shortageUNIISPLATC A10AE04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerSanofi-Aventis U.S. LLC
CountryUS (United States)
ATC codeA10AE04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 0
No packs registered.
Annotations
UNII (FDA Substance ID)
2ZM8CX04RZ
INSULIN GLARGINE
RxCUI 274783
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension
Raw payload (JSON)
{
"unii": {
"unii": "2ZM8CX04RZ",
"rxcui": "274783",
"inchikey": null,
"display_name": "INSULIN GLARGINE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"c9561d96-124d-48ca-982f-0aa1575bff36": {
"match": "brand_token",
"title": "TOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION TOUJEO MAX (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]",
"spl_version": "25",
"published_date": "2025-06-12"
}
},
"productid": "0024-5869_49201ad7-68f7-407c-959f-852591703f96",
"productndc": "0024-5869",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN GLARGINE",
"shortage_reason": "Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension",
"shortage_status": "current",
"proprietary_name": "TOUJEO",
"active_ingred_unit": "U/mL",
"application_number": "BLA206538",
"marketing_category": "BLA",
"nonproprietary_name": "insulin glargine",
"start_marketing_date": "20150215",
"active_numerator_strength": "300"
}Related drugs
Other records sharing ATC code A10AE04.
Access this data programmatically
Query TOUJEO and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.